Eurosurv. Continued circulation of mpox: an epidemiological and phylogenetic assessment, European Region, 2023 to 2024

[tetano]

• Aisling M Vaughan[SUP]1,*[/SUP] , Mohammed Afzal[SUP]2,*[/SUP] , Priyanka Nannapaneni[SUP]2[/SUP] , Mathias Leroy[SUP]1[/SUP] , Xanthi Andrianou[SUP]2[/SUP] , Jeffrey Pires[SUP]1[/SUP] , Silvia Funke[SUP]2[/SUP] , Celine Roman[SUP]1[/SUP] , Juliana Reyes-Uruena[SUP]2[/SUP] , Stephan Aberle[SUP]3[/SUP] , Aristos Aristodimou[SUP]4[/SUP] , Gudrun Aspelund[SUP]5[/SUP] , Kirsty F Bennet[SUP]6[/SUP] , Antra Bormane[SUP]7[/SUP] , Anna Caraglia[SUP]8[/SUP] , Hannah Charles[SUP]6[/SUP] , Emilie Chazelle[SUP]9[/SUP] , Iva Christova[SUP]10[/SUP] , Orna Cohen[SUP]11[/SUP] , Costas Constantinou[SUP]4[/SUP] , Simon Couvreur[SUP]12[/SUP] , Asuncion Diaz[SUP]13[/SUP] , Kateřina Fabiánová[SUP]14[/SUP] , Federica Ferraro[SUP]8[/SUP] , Marte Petrikke Grenersen[SUP]15[/SUP] , Eva Grilc[SUP]16[/SUP] , Tuula Hannila-Handelberg[SUP]17[/SUP] , Anne Kathrine Hvass[SUP]18[/SUP] , Derval Igoe[SUP]19[/SUP] , Klaus Jansen[SUP]20[/SUP] , Denisa Janță[SUP]21[/SUP] , Styliani Kaoustou[SUP]22[/SUP] , Anders Koch[SUP]18,23[/SUP] , Mirjana Lana Kosanovic Licina[SUP]24[/SUP] , Stefka Krumova[SUP]10[/SUP] , Anton Labutin[SUP]25[/SUP] , Raskit Lachmann[SUP]20[/SUP] , Amaryl Lecompte[SUP]12[/SUP] , Rémi Lefrançois[SUP]26[/SUP] , Viktorija Leitena[SUP]7[/SUP] , Kirsi Liitsola[SUP]17[/SUP] , Ivan Mlinarić[SUP]27[/SUP] , Zohar Mor[SUP]11,28[/SUP] , Martha Neary[SUP]29[/SUP] , Alina Novacek[SUP]30[/SUP] , Magnus Wenstøp Øgle[SUP]15[/SUP] , Hana Orlíková[SUP]14,31[/SUP] , Kalliopi Papadima[SUP]22[/SUP] , Moa Rehn[SUP]32[/SUP] , Malgorzata Sadkowska-Todys[SUP]33[/SUP] , Anca Sîrbu[SUP]21[/SUP] , Klara Sondén[SUP]32[/SUP] , Berta Suárez[SUP]34[/SUP] , Marianna Thordardottir[SUP]5[/SUP] , Paula Vasconcelos[SUP]35[/SUP] , Joao Vieira Martins[SUP]36[/SUP] , Karolina Zakrzewska[SUP]33[/SUP] , Marc-Alain Widdowson[SUP]1,**[/SUP] , Céline M Gossner[SUP]2,**[/SUP]

During the summer of 2023, the European Region experienced a limited resurgence of mpox cases following the substantial outbreak in 2022. This increase was characterised by asynchronous and bimodal increases, with countries experiencing peaks at different times. The demographic profile of cases during the resurgence was largely consistent with those reported previously. All available sequences from the European Region belonged to clade IIb. Sustained efforts are crucial to control and eventually eliminate mpox in the European Region.
​

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.27.2400330